Start Date
Immediate
Expiry Date
28 Nov, 25
Salary
269000.0
Posted On
28 Aug, 25
Experience
10 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Accountability, Government, Diverse Groups, Management Skills
Industry
Financial Services
DESCRIPTION
The Director, Compliance Business Partner is responsible for leading the development, implementation, and continuous enhancement of a robust compliance program across assigned business area(s) within the company’s Human Pharma business unit. This role serves as a strategic business partner, providing proactive guidance and practical solutions to support daily operations. The Director ensures the implementation of effective compliance controls, comprehensive training, and monitoring programs, and drives timely remediation efforts to uphold regulatory standards. By offering risk-based insights, the Director advises leadership on achieving business objectives ethically and efficiently.
Collaboration is key—this role works closely with business partners and cross-functional teams within the Compliance & Integrity Department to foster a culture of integrity and continuous improvement.
The Director, Compliance Business Partner (CBP) is a pivotal role providing strategic guidance and compliance oversight for business initiatives within the Cardio-Renal-Metabolic therapeutic area, with a particular focus on Obesity and Liver Health. This role requires a proactive and collaborative leader who can build trusted relationships with senior leaders across Medicine and Commercial functions. The CBP will deliver solution-oriented compliance advice, ensure appropriate controls and training are in place, and support the product lifecycle—from proof of concept through post-launch. Success in this role means being recognized as a valued and integral partner to the Cardio-Renal-Metabolic therapeutic area.
This role has a flexible hybrid onsite work schedule 2-3 days per week in our Ridgefield, CT headquarters dependent on business needs.
REQUIREMENTS
Eligibility Requirements :